PolarCool: PolarCap® soon next to every defibrillator in the world of sports - Emergers
With strong clinical evidence to treat the growing problem of Sports Related Concussions (SRCs), PolarCool offers the PolarCap® that is proven to reduce long term absence by up to 80%. With 38 systems installed on a subscription basis, including a league-wide agreement with the SHL, PolarCool targets 100 new deals in 2023, to be doubled annually in the following years supporting a target Market Cap of SEK 80m in 12-24 months. Adjusted for a further capital requirement this translates to SEK 2.3 per share. Long term, management is confident to reach 1500 systems installed by 2026, supporting close to a half billion SEK valuation.
Länk till analysen i sin helhet: https://www.emergers.se/polarcool_a/